Prognostic significance of FXYD-3 in Patients who underwent resection of Colorectal Liver Metastases
| Field | Value | Language |
| dc.contributor.author | Bhimani, Nazim | |
| dc.date.accessioned | 2019-05-06 | |
| dc.date.available | 2019-05-06 | |
| dc.date.issued | 2019-05-03 | |
| dc.identifier.uri | http://hdl.handle.net/2123/20359 | |
| dc.description | Workplace Project Portfolio by Nazim Bhimani. Supervisors: Associate Professor Patrick Kelly and Professor Thomas Hugh | en_AU |
| dc.description.abstract | Background: Colorectal cancer (CRC) is the third most common cancer in Australia and approximately 50% of these patients will eventually develop colorectal liver metastases (CRLM) [1-3]. Many organs such as the breast, pancreas, lung, stomach and rectum have varying expression levels of FXYD-3. There are conflicting results from studies examining the relationship between FXYD-3 expression and CRC, and to date there have been no studies on the expression of FXYD-3 in CRLM. Aims: The aim of this study is to determine the prevalence of FXYD-3 expression in patients with primary CRC and those that develop CRLM, and determine if FXYD-3 expression is associated with survival after resection of CRLM. | en_AU |
| dc.language.iso | en_AU | en_AU |
| dc.rights | The author retains copyright of this work | en |
| dc.subject | FXYD-3 | en_AU |
| dc.subject | colorectal cancer | en_AU |
| dc.subject | colorectal liver metastasis, | en_AU |
| dc.title | Prognostic significance of FXYD-3 in Patients who underwent resection of Colorectal Liver Metastases | en_AU |
| dc.type | Article | en_AU |
| usyd.department | Biostatistics, School of Public Health | en_AU |
Associated file/s
Associated collections